Murray Wood: Who's hot... and who's not
Every Friday, Murray Wood takes a look at the week's news and decides who's hot... and who's not. This week's list inclu...
ABUJA, Nigeria (AP) — The World Health Organization declared the Ebola disease outbreak caused by a rare virus in Congo and neighbouring Uganda a public health emergency of international concern on Sunday, after more than 300 suspected cases and 88 deaths.
WHO said that the outbreak doesn’t meet the criteria of a pandemic emergency like COVID-19, and advised against the closure of international borders.
Read more:
- Canadian in isolation tests ‘presumptive positive’ for hantavirus
- Three new Hepatitis A cases in Sask. after initial exposure: SHA
- Public health agency says World Cup poses high risk of measles spread
WHO said on X that a laboratory-confirmed case has also been reported in Congo’s capital, Kinshasa, which is about 1,000 kilometres (620 miles) from the outbreak’s epicentre in the eastern province of Ituri, suggesting a possible wider spread.
It said the patient had visited Ituri and that other suspected cases have also been reported in North Kivu province, which is one of Congo’s most populous and borders Ituri.
— World Health Organization (WHO) (@WHO) May 17, 2026
On Sunday, the rebel government of Goma, Eastern Congo’s largest city, confirmed in a statement that the first confirmed case of Ebola was detected in the city.
The infected person travelled from Ituri province and was currently under isolation, the statement said. Goma was the site of a rapid rebel offensive in early 2025, and the conflict between the Congolese armed forces and the Rwanda-backed M23 rebel paramilitary group has displaced hundreds of thousands.
Map showing the location of Ituri province in the Democratic Republic of the Congo. (AP Digital Embed)
Ebola is highly contagious and can be contracted via bodily fluids such as vomit, blood or semen. The disease it causes is rare, but severe and often fatal.
WHO’s emergency declaration is meant to spur donor agencies and countries into action. By WHO’s standards, it shows the event is serious, there is a risk of international spread and it requires a coordinated international response.
The global response to previous declarations has been mixed. In 2024, when WHO declared mpox outbreaks in Congo and elsewhere in Africa a global emergency, experts at the time said that it did little to get supplies like diagnostic tests, medicines and vaccines to affected countries quickly.
It’s hard to treat a variant of Ebola
Health authorities say the current outbreak, first confirmed on Friday, is caused by the Bundibugyo virus, a rare variant of the Ebola disease that has no approved therapeutics or vaccines.
Although more than 20 Ebola outbreaks have taken place in Congo and Uganda, this is only the third time that the Bundibugyo virus has been detected.
Congo accounts for all except two of the cases, both of which were reported in Uganda, WHO said.
The Bundibugyo virus was first detected in Uganda’s Bundibugyo district during a 2007-2008 outbreak that infected 149 people and killed 37. The second time was in 2012, in an outbreak in Isiro, Congo, where 57 cases and 29 deaths were reported.
Africa Centres for Disease Control and Prevention Director-General Dr. Jean Kaseya said Saturday that a high number of active cases remain in the community, particularly in Mongwalu, where the first cases were reported, “significantly complicating containment and contact tracing efforts.”
Violent conflict with militants, some backed by the Islamic State group, as well as constant population movement because of mining, both within Congo and across the border in Uganda, have also posed a major challenge to response efforts.
Officials first reported the spread of the disease in Ituri province, close to Uganda and South Sudan, on Friday. On Saturday, the Africa CDC reported 336 suspected cases and 87 deaths in Congo.
A health official uses a thermometer to screen people in front of Kibuli Muslim Hospital in Kampala, Uganda, Saturday, May 16, 2026. (AP Photo/ Hajarah Nalwadda)
“There are significant uncertainties to the true number of infected persons and geographic spread associated with this event at the present time. In addition, there is limited understanding of the epidemiological links with known or suspected cases,” WHO Director-General Tedros Adhanom Ghebreyesus said.
The two cases in Uganda include one person whom officials said had travelled from Congo and died at a hospital in Uganda’s capital, Kampala, and another WHO said had also travelled from Congo.
WHO said that the high percentage of positive cases among samples tested, the spread to Kampala and Uganda and the clusters of deaths across Ituri “all point toward a potentially much larger outbreak than what is currently being detected and reported, with significant local and regional risk of spread.”
Congo outbreak killed 50 before it was detected
Kaseya said that slow detection delayed the response and gave the virus time to spread.
“This outbreak started in April. So far, we don’t know the index case. It means we don’t know how far is the magnitude of this outbreak,” Kaseya said, using a term for the first detectable case of an epidemic.
The earliest known suspected case, a 59-year-old man, developed symptoms on April 24 and died at a hospital in Ituri on April 27.
By the time health authorities were first alerted to the outbreak via social media on May 5, 50 deaths had already been recorded, the Africa CDC said.
WHO said that at least four deaths have been reported among healthcare workers who showed Ebola symptoms.
Shanelle Hall, principal adviser to the head of Africa CDC, told reporters Saturday that there were four therapeutics under consideration for the Bundibugyo virus, but no vaccine was being actively considered.
A bigger issue is that even existing vaccines and therapeutics for other Ebola viruses aren’t manufactured in Africa.
Africa’s struggle to get vaccines from richer countries during the COVID-19 pandemic spurred different efforts to accelerate its capacity to manufacture shots, but resources remain scarce.
Kaseya said that the demand for a vaccine for a rare virus like Bundibugyo, which isn’t as deadly as the Ebola Zaire prominent in Congo’s past outbreaks, has been the recurring issue in discussions with pharmaceutical companies over vaccine manufacturing,
“If we are serious in this continent, we need to manufacture what we need,” he said. “We cannot every single day look for others to come to tell us what they are doing.”
Read more:
